ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Australian State/Territory : NSW
Research Topic : Epithelial inflammation
Clear All
Filter by Field of Research
Respiratory Diseases (4)
Cardiology (incl. Cardiovascular Diseases) (2)
Medical Virology (2)
Medical and Health Sciences not elsewhere classified (2)
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (1)
Cancer Cell Biology (1)
Clinical sciences not elsewhere classified (1)
Gastroenterology and Hepatology (1)
Haematology (1)
Innate Immunity (1)
Systems Physiology (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (18)
Filter by Status
Closed (18)
Filter by Scheme
Project Grants (10)
Early Career Fellowships (2)
NHMRC Project Grants (2)
Centres of Research Excellence (1)
NHMRC Postgraduate Scholarships (1)
Program Grants (1)
Research Fellowships (1)
Filter by Country
Australia (18)
Filter by Australian State/Territory
NSW (18)
ACT (2)
QLD (2)
SA (1)
WA (1)
  • Researchers (0)
  • Funded Activities (18)
  • Organisations (0)
  • Funded Activity

    Inhibition Of Cellcell Actin-based Motility During Poxvirus Infection By The Kinase Inhibitor Glivec

    Funder
    National Health and Medical Research Council
    Funding Amount
    $92,950.00
    Summary
    Although smallpox, one of the deadliest human pathogens, was eradicated in 1980, the current global climate has resulted in fears that smallpox may be used as a biological weapon. Unfortunately the smallpox vaccine poses a serious health hazard to certain people. We have shown that Glivec, a drug used to treat cancer, has potent anti-viral affects on poxvirus replication. This project will test the effectiveness of Glivec in treating smallpox in an animal model and study how it acts.
    More information
    Funded Activity

    Defining The Mechanism Of Assembly Of Herpes Simplex Virus In The Neuronal Growth Cone And Its Subsequent Exit To Epithelial Cells

    Funder
    National Health and Medical Research Council
    Funding Amount
    $774,624.00
    Summary
    Herpes simplex virus (HSV) causes dormant infection of nerve cell bodies near the spine. It periodically reactivates to be transported along nerves to the skin where it causes oral, genital or neonatal herpes and mediates HIV superinfection. HSV assembles into its final form in the terminal part of the axon just prior to crossing into skin. Elucidating the mechanism of HSV assembly and exit will facilitate new strategies for antiviral agents and immune treatment for HSV and similar viruses.
    More information
    Funded Activity

    Galectin-3 And Phagocyte Function In Severe Asthma

    Funder
    National Health and Medical Research Council
    Funding Amount
    $698,084.00
    Summary
    Asthma, a major chronic inflammatory disease affects more than 2 million Australians. Neutrophilic severe asthma is not responsive to current therapies. We have recently made a significant advance in understanding neutrophilic asthma, reporting low levels of a protein called galectin-3 (gal-3). In this project we will explore the role of gal-3 its effect on the resolution of inflammation. This study will result significantly advance the knowledge of the mechanisms of neutrophilic severe asthma.
    More information
    Funded Activity

    Interactions Between Genes That Cause Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $554,808.00
    Summary
    Much of the death and suffering caused by cancer is associated with secondary tumours, but alot remains to be learned about how cancer spreads through the patient's body. This project will determine how genes that enable the growth of tumours work with other genes that enable cancer cells to detach from the tumour, enabling them to enter the bloodstream and form secondary tumours in other organs.
    More information
    Funded Activity

    A Novel Macrophage Lineage In Inflammation And Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $772,857.00
    Summary
    Macrophages are an important haematopoietic cell type that has been implicated in inflammatory and cancerous diseases. In our preliminary work we have discovered a new macrophage subset, termed the perivascular macrophage, in breast cancer. The aim of this proposal is to investigate the origin of these cells, and the role they play in breast cancer. This will tell us how we might be able to manipulate the functions of these cells in order to curtail breast cancer progression.
    More information
    Funded Activity

    Gene Expression Biomarkers Predict Severe Asthma Inflammatory Phenotype, Activation Mechanisms And Treatment Response

    Funder
    National Health and Medical Research Council
    Funding Amount
    $465,627.00
    Summary
    Asthma is now recognised to be made up of several disease variants or phenotypes, which are likely to have different underlying causes and mechanisms. We lack understanding of how to identify phenotypes of asthma and how they work, and this is delaying research that will lead to improvements in treatments and patient care. This is particularly important in people with severe disease. This grant will establish a gene test to identify asthma phenotype, and further understand mechanisms and treatme .... Asthma is now recognised to be made up of several disease variants or phenotypes, which are likely to have different underlying causes and mechanisms. We lack understanding of how to identify phenotypes of asthma and how they work, and this is delaying research that will lead to improvements in treatments and patient care. This is particularly important in people with severe disease. This grant will establish a gene test to identify asthma phenotype, and further understand mechanisms and treatment responses.
    Read more Read less
    More information
    Funded Activity

    Intravascular Leukocyte Trafficking During Thromboinflammation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $668,742.00
    Summary
    Unblocking blood vessels to treat heart attack and stroke can unfortunately cause a paradoxical worsening of organ damage, due to increased inflammation upon blood flow restoration. We have identified a novel way in which this side-effect is regulated by the small blood clotting cells platelets, and the protein fibrin. We will investigate ways to reduce the pro-inflammatory role for platelets, and define safer clot busting treatments.
    More information
    Funded Activity

    National Clinical Centre Of Research Excellence In Severe Asthma

    Funder
    National Health and Medical Research Council
    Funding Amount
    $2,597,952.00
    Summary
    Severe Asthma remains a large burden for the Australian community. It does not respond to current management approaches. We will develop and implement a targetted therapy approach to severe asthma that will involve assessment of needs of people with severe asthma, community burden form severe asthma, biomarkers and linked treatment strategies, as well as knowledge transfer tools and training of the health and medical workforce.
    More information
    Funded Activity

    Inflammatory Mediators Of Liver Injury In Chronic Hepatitis C

    Funder
    National Health and Medical Research Council
    Funding Amount
    $349,336.00
    Summary
    Presently, liver disease from chronic hepatitis C and obesity represents a major health problem. Overall, approximately 50% of Australians with chronic hepatitis C are obese and these patients are at significantly increased risk of rapidly progressing to liver failure. It is now recognized that fat derived factors play an important role in regulating inflammatory responses. This grant proposal aims to gain insight into how liver and fat derived inflammatory factors interact to promote increased .... Presently, liver disease from chronic hepatitis C and obesity represents a major health problem. Overall, approximately 50% of Australians with chronic hepatitis C are obese and these patients are at significantly increased risk of rapidly progressing to liver failure. It is now recognized that fat derived factors play an important role in regulating inflammatory responses. This grant proposal aims to gain insight into how liver and fat derived inflammatory factors interact to promote increased liver damage in chronic hepatitis C and obesity.
    Read more Read less
    More information
    Funded Activity

    The Role Of Novel G-Protein Coupled Receptors In Immunity And Inflammatory Diseases

    Funder
    National Health and Medical Research Council
    Funding Amount
    $69,684.00
    Summary
    Recent advances in molecular biology techniques have resulted in the identification of many novel GPCRs. Novel GPCRs expressed selectively on immune cells display a potential target for novel therapies for inflammatory diseases such as Asthma and Rheumatoid arthritis. This project aims to define the activity and significance of a novel group of GPCRs, the GPR40 family. Outcomes of this project will be further understanding of immune cell development and inflammatory disease development.
    More information

    Showing 1-10 of 18 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback